Back
Repligen Stock Price Chart
Sponsored
RGEN
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
58
RGEN
Repligen
Last Price:
145.74
Seasonality Move:
-3.11%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- The current trend is relatively stagnant and RGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Repligen Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 141.87 | Buy |
20-day SMA: | 145.06 | Sell |
50-day SMA: | 145.99 | Sell |
200-day SMA: | 164.85 | Sell |
8-day EMA: | 141.63 | Buy |
20-day EMA: | 144.73 | Sell |
50-day EMA: | 146.21 | Sell |
200-day EMA: | 156.61 | Sell |
Repligen Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.5 | Sell |
Relative Strength Index (14 RSI): | 45.74 | Sell |
Chaikin Money Flow: | 433944 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (141.15 - 152.93) | Sell |
Bollinger Bands (100): | (130.24 - 163.08) | Sell |
Repligen Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Repligen Stock
Is Repligen Stock a Buy?
- Repligen share price is 142.10 while RGEN 8-day simple moving average is 141.87, which is a Buy signal.
- The stock price of RGEN is 142.10 while Repligen 20-day SMA is 145.06, which makes it a Sell.
- Repligen 50-day simple moving average is 145.99 while RGEN share price is 142.10, making it a Sell technically.
- RGEN stock price is 142.10 and Repligen 200-day simple moving average is 164.85, creating a Sell signal.
RGEN Technical Analysis vs Fundamental Analysis
Repligen Stock Info
Market Cap:
7.96B
Price in USD:
142.10
Share Volume:
718.43K
Repligen 52-Week Range
52-Week High:
211.13
52-Week Low:
110.45
Buy
58
Repligen (RGEN)
is a Buy
Repligen Share Price Forecast
-
What is the Repligen stock price today?
The Repligen stock price is 142.10 USD today. -
Will RGEN stock go up or go down?
Repligen> share price is forecast to RISE/FALL based on technical indicators -
Is Repligen overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Repligen is not overvalued.
Is Repligen Stock a Buy?
- Repligen share price is 142.10 while RGEN 8-day exponential moving average is 141.63, which is a Buy signal.
- The stock price of RGEN is 142.10 while Repligen 20-day EMA is 144.73, which makes it a Sell.
- Repligen 50-day exponential moving average is 146.21 while RGEN share price is 142.10, making it a Sell technically.
- RGEN stock price is 142.10 and Repligen 200-day simple moving average is 156.61, creating a Sell signal.
Fundamental Analysis of Repligen
Is Repligen a good investment?
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.29 per share, and an increase next year of $0.46 per share.
Technical Analysis of Repligen
Should I short Repligen stock?
- RGEN Moving Average Covergence Divergence (MACD) indicator is -2.5, suggesting Repligen is a Sell
- Repligen Relative Strength Index (RSI) is 45.74, which suggest Repligen is oversold
- The Bollinger Bands (25) for Repligen is (141.15 - 152.93), which suggest Repligen is a Sell
- The Bollinger Bands (100) for Repligen is (130.24 - 163.08), which suggest Repligen is a Sell
* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.